NMTRQ — 9 Meters Biopharma Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$1.87m
Annual income statement for 9 Meters Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 18.2 | 26.6 | 60.9 | 36.8 | 42 |
| Operating Profit | -18.2 | -26.6 | -60.9 | -36.8 | -42 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -24.2 | -27 | -61.5 | -36.8 | -43.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -24.2 | -27 | -61.5 | -36.8 | -43.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -24.2 | -27 | -61.5 | -36.8 | -43.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -24.2 | -27 | -61.5 | -36.8 | -43.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -19.5 | -15.6 | -5.38 | -2.57 | -3.38 |